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Following DES Implantation
Predict Long-Term Outcomes?*
Kenichi Sakakura, MD, Michael Joner, MD, Renu Virmani, MDSEE PAGE 788A recent publication by Kim et al. (1) showedthat there are 3 optical coherence tomogra-phy (OCT) patterns of the neointimal tissue
(homogenous, heterogeneous, and layered) following
stent implantation in swine coronary arteries. The
heterogeneous pattern could histologically have
ﬁbrous tissue, ﬁbrin, inﬂammation, and neovasculari-
zation in swine (1). The same pattern has also been
described in patients without histologic validation
(2). We reported that the presence of foamy macro-
phages is characterized by high peak intensity and
steep attenuation of OCT light, whereas organized
thrombus was identiﬁed as dark areas with low-
intensity images and a weak attenuation rate (3).
Therefore, neoatherosclerosis will also have a hetero-
geneous pattern. On the other hand, a thorough vali-
dation of OCT to detect neoatherosclerosis has not
been accomplished to date. Recently neoatheroscle-
rosis, which is deﬁned as peristrut or luminal foamy
macrophage inﬁltrates with or without calciﬁcation,
ﬁbroatheromas, thin-cap ﬁbroatheromas, and rup-
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Medtronic, and W. L. Gore.important mechanism of late stent failure (5). In the
past, OCT has frequently been used to detect intra-
stent rupture and erosion, which only represent the
ﬁnal stage of neoatherosclerosis formation in the
aftermath of stent implantation. Accuracy of OCT to
determine early stages of neoatherosclerosis may
not be sufﬁciently speciﬁc for thin-cap ﬁbroatheroma
or ﬁbroatheroma (6,7), or more importantly, foamy
macrophage inﬁltrates. Nevertheless, OCT is the
only contemporary imaging technology that enables
us to characterize neointima in vivo at high resolu-
tion. Serial changes in qualitative characteristics of
the neointima have been previously reported by
Kim et al. (8), who investigated 72 patients with 76
drug-eluting stented (DES) lesions that had been
imaged by OCT at 9 months and 2 years. They found
that lipid-laden neointima and thin-cap ﬁbroather-
oma were more frequently observed at 2-year
follow-up than at 9 months (8).In this issue of iJACC, Kim et al. (9) report their
ﬁndings of a prospective observational study that
aimed to investigate clinical outcomes relative to
different OCT-based neointimal patterns following
DES placement. A total of 368 lesions in 336 patients,
who received DES placement and had a follow-up
OCT examination, were categorized in groups of
homogenous (n ¼ 227 [61.7%] lesions in 208 patients),
heterogeneous (n ¼ 79 [21.5%] lesions in 73
patients), or layered (n ¼ 62 [16.8%] lesions in 52
patients) neointimal pattern. The median interval
between DES placement and OCT follow-up was
between 8 and 9 months, and there were no signiﬁ-
cant differences among groups. Major adverse cardiac
events (a composite of cardiac death, nonfatal
myocardial infarction, or target lesion revasculariza-
tion) were compared according to the previously
deﬁned neointimal patterns. Following multivariate
analysis, independent predictors for the presence of
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797heterogeneous neointima were both age and initial
clinical presentation as acute coronary syndrome.
Although this study included ﬁrst-generation DES
(86 sirolimus-eluting stents and 39 paclitaxel-eluting
stents) as well as second-generation DES (147
zotarolimus-eluting stents, 62 everolimus-eluting
stents, and 34 biolimus-eluting stents), DES type
was not associated with the presence of heteroge-
neous neointima. At an average follow-up of 31
months, major adverse cardiac events occurred more
frequently in the heterogeneous group (13.7%) than in
the nonheterogeneous groups (homogenous [2.9%]
or layered [7.3%], p ¼ 0.001) (9). The current study
clearly proposes a novel link between heterogeneous
neointimal pattern by OCT and the risk of future
cardiovascular events, which suggests a new
approach to future individualized therapy such as
aggressive medical therapy for the high-risk group
deﬁned by OCT imaging.
Despite this appealing innovation relevant for the
clinical application of OCT imaging, a major limitation
of the current study pertains to the lack of histo-
pathologic characterization of heterogeneous neo-
intimal tissue, which could have clinical implications.
The lack of accuracy in detecting neoatherosclerosis
in the clinical setting can also be seen by the fact thatFIGURE 1 Prevalence of Heterogeneous Neointima and Neoatherosc
The prevalence of heterogeneous neointima (pink bar) and neoatherosc
each study is highlighted in the table. AP ¼ angina pectoris; CSA ¼ cros
hyperplasia; NSTEMI¼ non–ST-segment elevation myocardial infarction;only 3 patients had conventional OCT signs of neo-
atherosclerosis in the present study population, and
these patients were excluded from analysis. Also, at
8 and 9 months following stent implantation, the
prevalence of neoatherosclerosis within DES is less in
the present study (0.9%) as compared to published
data from histopathology studies (4,10), OCT sur-
veillance studies by other groups (11), or the same
group (8,12). The reported prevalence of neo-
atherosclerosis relative to the frequency of hetero-
geneous neointima in the current study is shown in
Figure 1. A possible explanation for this discrepancy is
that tissue characterization was determined from a
representative OCT frame (at the minimal lumen
cross-sectional area) in the present study (9), whereas
it was determined from several (every 1-mm) OCT
frames in the previous study (8). Owing to heteroge-
neity in vascular healing after stent implantation, it is
likely that the optical appearance of neointimal tissue
may show substantial variation within the entire
pullback, and this ﬁnding may be even more pro-
nounced when DES are implanted in the setting of
acute coronary syndrome (13).
On the other hand, it needs to be acknowledged
that histopathological clariﬁcation of tissue compo-
sition is inherently absent in patients undergoinglerosis
lerosis (green bars) reported by different groups is illustrated and
s-sectional area; DES ¼ drug-eluting stent(s); NIH ¼ neointimal
OCT¼ optical coherence tomography; TCFA ¼ thin-cap ﬁbroatheroma.
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Therefore, valuable insights may be drawn from
innovative attempts to characterize neointimal tissue
as recently performed by our group. Using OCT
grayscale signal intensity analysis was helpful for the
detection of immature neointimal tissue including
inﬂammation, ﬁbrin, and macrophage inﬁltration
and incomplete endothelialization (14). Qualitative
assessment of neointimal tissue using OCT-based
grayscale signal intensity analysis may further facili-
tate the identiﬁcation of patients at risk for future
events.
Clinical implications of the present study need to
be elaborated. Because the homogenous pattern by
OCT corresponds to normal neointima (3), both het-
erogeneous and layered patterns should be consid-
ered abnormal neointima. Consequently, abnormal
neointima likely includes histopathological sub-
strates such as inﬂammation, ﬁbrin accumulation,
organized thrombus, foamy macrophage, micro-
calciﬁcation, and angiogenesis, which are impossible
to differentiate from one another using current OCT
devices (3). Although Kim et al. (9) excludedconventional OCT-deﬁned neoatherosclerosis cases,
the true prevalence of neoatherosclerosis may have
been underestimated in the current study owing to
inappropriate clinical validation. In this regard, a
substantial number of neoatherosclerosis cases may
have been underdiagnosed in the current study pop-
ulation, especially in the group of heterogeneous
tissue appearance.
In summary, Kim et al. (9), for the ﬁrst time,
showed an association between the presence of het-
erogeneous OCT characteristics and future clinical
events in patients undergoing routine OCT surveil-
lance after DES implantation. Although the nature of
heterogeneous tissue appearance and future cardio-
vascular events cannot be causally established from
the current study, the investigators provided impor-
tant information justifying the incorporation of OCT
in clinical practice.
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